MLL
MRNA icon

Moody Lynn & Lieberson’s Moderna MRNA Stock Holding History

Moody Lynn & Lieberson’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,230
Closed -$939K – 227
2022
Q4 		$939K Buy
+5,230
New +$855K 0.09% 111
2021
Q4 		– Sell
-800
Closed -$308K – 244
2021
Q3 		$308K Sell
800
-178
-18% -$65.6K 0.02% 192
2021
Q2 		$230K Buy
+978
New +$175K 0.02% 206
2020
Q1 		– Sell
-80,820
Closed -$1.58M – 189
2019
Q4 		$1.58M Buy
+80,820
New +$1.43M 0.15% 98

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Moody Lynn & Lieberson's MRNA Position: Q1 2023 in Review

Moody Lynn & Lieberson sold out of Moderna (MRNA) in Q1 2023, closing a stake of 5,230 shares — an estimated $939K sold.

Moody Lynn & Lieberson first reported a position in MRNA in Q4 2019 and held it in 4 quarters. The position peaked at $1.58M in Q4 2019. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Moody Lynn & Lieberson reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Moody Lynn & Lieberson sold 5,230 Moderna shares in Q1 2023, an estimated $939K.
  • Moody Lynn & Lieberson first reported a position in Moderna in Q4 2019 and held it in 4 quarters.
  • Moody Lynn & Lieberson's Moderna position peaked at $1.58M in Q4 2019.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Moody Lynn & Lieberson's 13F filing for Q1 2023, filed 2 May 2023.